nivolumab
bms
['gu ', 'nivo', 'rcc,(-irccs),(-srcc),(-urcc)', 'prosper,trial']
in a gu session chaired by , mohamad allaf presents the prosper trial of peri-operative nivo in rcc. negative for rfs... os immature. tox as expected.
note the significant upstaging post surgery.
#esmo2022 
Enjoying oncology, without meaning to sound too cynical